Axcella Health Inc

NASDAQ:AXLA   3:59:56 PM EDT
5.57
+0.17 (+3.15%)
Other Pre-Announcement

Axcella Reports Q3 Loss Per Share $0.34

Published: 11/12/2020 12:51 GMT
Axcella Health Inc (AXLA) - Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update.
Axcella Health Inc - Qtrly Loss per Share $0.34.
Axcella Health Inc - Phase 2b Serial Biopsy Clinical Trial Enrolling Adult Patients With Nash Expected to Be Initiated in First Half of 2021.
Axcella Health Inc - Phase 2 Clinical Trial Enrolling Subjects With Liver Cirrhosis Expected to Be Initiated in First Half of 2021.
Axcella Health Inc - Expects to Communicate Decision Whether to Enroll Additional Subjects With Sickle Cell Disease in Axa4010-001 Study by Early 2021.